BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2509124)

  • 1. Comparison of three methods for the determination of serum alpha-1-antitrypsin in patients with pulmonary diseases.
    Prinsen JH; Schweisfurth H; Rasche B; Breuer J
    Clin Physiol Biochem; 1989; 7(3-4):198-202. PubMed ID: 2509124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
    Fischbach W; Deubel M; Boege F; Mössner J
    Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus.
    Hashemi M; Naderi M; Rashidi H; Ghavami S
    Diabetes Res Clin Pract; 2007 Feb; 75(2):246-8. PubMed ID: 16875754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low serum alpha-1-antitrypsin specific activity in monoclonal gammopathies.
    Jelić-Ivanović Z; Stanković B; Topić A; Spasojević-Kalimanovska V; Spasić S
    Panminerva Med; 2000 Mar; 42(1):17-21. PubMed ID: 11019599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of serum trypsinogen-2 and trypsin-2-alpha1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis.
    Hedström J; Kemppainen E; Andersén J; Jokela H; Puolakkainen P; Stenman UH
    Am J Gastroenterol; 2001 Feb; 96(2):424-30. PubMed ID: 11232685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
    Hollander C; Westin U; Wallmark A; Piitulainen E; Sveger T; Janciauskiene SM
    BMC Pulm Med; 2007 Jan; 7():1. PubMed ID: 17261175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal alpha1--antitrypsin in healthy and intestinal-disorder Thai children.
    Tangsilsat D; Atamasirikul K; Treepongkaruna S; Bed SN; Sumritsopak R; Kunakorn M
    J Med Assoc Thai; 2007 Jul; 90(7):1317-22. PubMed ID: 17710971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypsin inhibitory capacity in vernal keratoconjunctivitis.
    Ghavami S; Hashemi M; de Serres FJ; Bajestani SN; Mehrabifar H; Leonardi A
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):264-9. PubMed ID: 17197542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels of alpha-1 antitrypsin in chronic bronchopathies].
    Olivieri D; Brancaccio L; Bocchino M
    Arch Monaldi; 1973; 28(5):423-38. PubMed ID: 4215398
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of alpha-1-antitrypsin and alpha-2-pregnancy-associated glycoprotein in the serum of patients with bronchial carcinoma].
    Homolka J; Voslárová Z; Malbohan I
    Z Erkr Atmungsorgane; 1987; 169(1):38-43. PubMed ID: 3118584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
    Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
    Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1-antitrypsin and chronic bronchitis in adult Nigerians.
    Awotedu AA; Adelaja AB
    Afr J Med Med Sci; 1990 Dec; 19(4):291-7. PubMed ID: 2127999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum trypsin inhibitory capacity and alpha 1-antitrypsin levels in liver cirrhosis and hepatoma.
    Theodoropoulos G; Archimandritis A; Tsomi A; Chloros G; Rigatos G; Angelopoulos B
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):195-7. PubMed ID: 225915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laser nephelometry. A better methodology?].
    Gaytán-Alcocér M
    Arch Invest Med (Mex); 1990; 21(2):79-86. PubMed ID: 2129476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum alpha1-antitrypsin in bronchopulmonary diseases and its changes in the course of cortisone treatment].
    Dalmasso F; Cardellino G; Garbagni R
    Bronches; 1975; 25(4):261-9. PubMed ID: 1081425
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects.
    Wood WG; Lüdemann J; Mitusch R; Heinrich J; Maass R; Frick U
    Clin Lab; 2000; 46(3-4):131-40. PubMed ID: 10791120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alpha-1-antitriypsin levels in patients with pseudoexfolative syndrome.
    Cumurcu T; Ozyurt H; Demir HD; Yardim H
    Curr Eye Res; 2008 Feb; 33(2):159-62. PubMed ID: 18293186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
    Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
    Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.